BASEL, Switzerland, Feb. 11, 2014 (GLOBE NEWSWIRE) -- Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today its results for the full financial year 2013 with a solid year-end cash position of CHF 273.9 million and a significantly reduced net loss of CHF 33.0 million. Basilea continued its focused investment into its key value-driving assets.
Help employers find you! Check out all the jobs and post your resume.
